A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : NAMs

Search Conditions:
Search Keyword : NAMs
Search Method : Exact match.
Research Area:

Abbreviation: NAMs
Appearance Frequency: 185 time(s)
Long forms: 29

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
negative allosteric modulators
(110 times)
(32 times)
PAMs (23 times)
mGluR5 (14 times)
mGlu5 (13 times)
2008 Allosteric potentiators of metabotropic glutamate receptor subtype 1a differentially modulate independent signaling pathways in baby hamster kidney cells.
new approach methodologies
(31 times)
(15 times)
POD (4 times)
iPSC (2 times)
NGRA (2 times)
2018 Accelerating the Pace of Chemical Risk Assessment.
nucleoside analogue mutations
(10 times)
Communicable Diseases
(4 times)
NRTI (4 times)
GRT (2 times)
HAART (2 times)
2003 Stavudine in the face of cross-resistance between HIV-1 nucleoside reverse transcriptase inhibitors: a review.
(4 times)
Molecular Biology
(1 time)
AL (1 time)
E. coli (1 time)
MALDI TOF (1 time)
2016 MALDI-TOF mass spectrometry analysis of proteins and lipids in Escherichia coli exposed to copper ions and nanoparticles.
new approach methods
(3 times)
Environmental Health
(1 time)
AOP (1 time)
DDT (1 time)
DNT (1 time)
2018 Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
mGluR5-negative allosteric modulators
(2 times)
(2 times)
mGluR5 (2 times)
ADAMS (1 time)
FXS (1 time)
2016 Negative Allosteric Modulation of mGluR5 Partially Corrects Pathophysiology in a Mouse Model of Rett Syndrome.
nanografted monolayers
(2 times)
(2 times)
--- 2012 Hybridization in nanostructured DNA monolayers probed by AFM: theory versus experiment.
nucleoside-associated mutations
(2 times)
HIV Infections
(1 time)
ART (1 time)
NNRTI (1 time)
NNRTIs (1 time)
2002 Genetic mechanisms of resistance to NRTI and NNRTI.
Nanoporous alumina membranes
(1 time)
Chemistry Techniques, Analytical
(1 time)
GDEs (1 time)
2019 Compact and efficient gas diffusion electrodes based on nanoporous alumina membranes for microfuel cells and gas sensors.
10  NASH-associated macrophages
(1 time)
Cell Biology
(1 time)
HSCs (1 time)
TREM2 (1 time)
2019 Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis.
11  Nerve agent metabolites
(1 time)
Chemistry Techniques, Analytical
(1 time)
EMPA (1 time)
GC (1 time)
IMPA (1 time)
2019 Determination of nerve agent metabolites in human urine by femtosecond laser ionization mass spectrometry using 2-(bromomethyl)naphthalene as a derivatizing reagent.
12  nerve- and airway-associated macrophages
(1 time)
AMs (1 time)
2020 Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties.
13  network-attacking mutations
(1 time)
Cell Biology
(1 time)
--- 2015 Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.
14  neural adhesion molecules
(1 time)
Genetics, Medical
(1 time)
GPNMB (1 time)
NTFs (1 time)
rhGPNMB (1 time)
2020 Altered expression of glycoprotein non‑metastatic melanoma protein B in the distal sciatic nerve following injury.
15  neutral autosomal microsatellite markers
(1 time)
Allergy and Immunology
(1 time)
AMOVA (1 time)
MHC (1 time)
Na (1 time)
2020 Evolutionary relationship and population structure of domestic Bovidae animals based on MHC-linked and neutral autosomal microsatellite markers.
16  nevus-associated melanomas
(1 time)
(1 time)
DNMs (1 time)
2018 Recognition of early melanoma: a monocentric dermoscopy follow-up study comparing de novo melanoma with nevus-associated melanoma.
17  new alternative methods
(1 time)
Laboratory Animal Science
(1 time)
MOA (1 time)
2019 Developing context appropriate toxicity testing approaches using new alternative methods (NAMs).
18  nominally anhydrous volcanic minerals
(1 time)
Chemistry Techniques, Analytical
(1 time)
FPA (1 time)
FTIR (1 time)
2010 Application of micro-FTIR imaging in the Earth sciences.
19  Non animal methodologies
(1 time)
Laboratory Animal Science
(1 time)
--- 2020 Non animal methodologies (NAMs): Research, testing, assessment and applications - ecopa Symposium 2019.
20  non-Asian males
(1 time)
(1 time)
AF (1 time)
EGFR (1 time)
LCSS (1 time)
2017 Survival of Asian Females With Advanced Lung Cancer in the Era of Tyrosine Kinase Inhibitor Therapy.
21  noncompetitive antagonism
(1 time)
(1 time)
nAChRs (1 time)
SAMs (1 time)
2015 Structurally similar allosteric modulators of alpha7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects.
22  nonlinear acoustic metamaterials
(1 time)
(1 time)
LAMs (1 time)
2017 Ultra-low and ultra-broad-band nonlinear acoustic metamaterials.
23  Normal AMs
(1 time)
Cell Biology
(1 time)
AM (1 time)
ARDS (1 time)
PSA (1 time)
1995 Impaired alveolar macrophage function in smoke inhalation injury.
24  normal atrial myocytes
(1 time)
(1 time)
AP (1 time)
HFAMs (1 time)
SR (1 time)
2017 Triggered intracellular calcium waves in dog and human left atrial myocytes from normal and failing hearts.
25  nuclear analytical methods
(1 time)
(1 time)
--- 2001 Determination of elements by nuclear analytical methods.
26  nucleic acid macromolecules
(1 time)
Drug Therapy
(1 time)
--- 2016 Critical considerations for developing nucleic acid macromolecule based drug products.
27  Nucleic acid mimics
(1 time)
Biomedical Engineering
(1 time)
--- 2017 Intracellular delivery of oligonucleotides in Helicobacter pylori by fusogenic liposomes in the presence of gastric mucus.
28  nucleoside reverse-transcriptase inhibitor-associated mutations
(1 time)
Communicable Diseases
(1 time)
HIV-1 (1 time)
2005 Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy: a randomized placebo-controlled trial.
29  nucleoside-associated resistance mutations
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
PI (1 time)
TAMs (1 time)
2004 Patterns of resistance emerging in HIV-1 from antiretroviral-experienced patients undergoing intensification therapy with tenofovir disoproxil fumarate.